Cargando…

Author Correction: Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer

Detalles Bibliográficos
Autores principales:	Gao, Jin-Hang, Wang, Chun-Hui, Tong, Huan, Wen, Shi-Lei, Huang, Zhi-Yin, Tang, Cheng-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888711/ https://www.ncbi.nlm.nih.gov/pubmed/35233045 http://dx.doi.org/10.1038/s41598-022-07805-0

Ejemplares similares

Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer
por: Gao, Jin-Hang, et al.
Publicado: (2015)

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
por: Board, R E, et al.
Publicado: (2009)

(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors
por: Desar, Ingrid M. E., et al.
Publicado: (2012)

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI
por: Beloueche-Babari, M, et al.
Publicado: (2013)

The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
por: Holt, S V, et al.
Publicado: (2012)

Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT)
por: Carvajal, Richard D., et al.
Publicado: (2015)

A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors
por: Leijen, Suzanne, et al.
Publicado: (2011)

The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
por: Song, Hao, et al.
Publicado: (2018)

Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
por: Song, Hao, et al.
Publicado: (2022)

Resistance to Selumetinib (AZD6244) in Colorectal Cancer Cell Lines is Mediated by p70S6K and RPS6 Activation()
por: Grasso, Silvina, et al.
Publicado: (2014)

Author Correction: Extracellular pyruvate kinase M2 promotes osteoclastogenesis and is associated with radiographic progression in early rheumatoid arthritis
por: Han, Dong Woo, et al.
Publicado: (2023)

Author Correction: Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2
por: Cheshenko, Natalia, et al.
Publicado: (2023)

Author Correction: Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response
por: Jiang, Weiwei, et al.
Publicado: (2023)

Author Correction: p21-activated kinase 4 suppresses fatty acid β-oxidation and ketogenesis by phosphorylating NCoR1
por: Shi, Min Yan, et al.
Publicado: (2023)

Cetuximab improves AZD6244 antitumor activity in colorectal cancer HT29 cells in vitro and in nude mice by attenuating HER3/Akt pathway activation
por: Zhang, Qin, et al.
Publicado: (2018)

Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Deng, Hongzhang, et al.
Publicado: (2021)

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
por: Coombes, R. C., et al.
Publicado: (2023)

Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib
por: Meraz, Ismail M., et al.
Publicado: (2023)

Author Correction: Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth
por: Lechertier, Tanguy, et al.
Publicado: (2023)

Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling
por: Wang, Luqi, et al.
Publicado: (2018)

Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells
por: Lee, Miso, et al.
Publicado: (2019)

Author Correction: Compatibility study of Danggui Buxue Tang on Chemical Ingredients, Angiogenesis and Endothelial Function
por: Lin, Ping-Lan, et al.
Publicado: (2022)

Author Correction: Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis
por: Singh, Mamta, et al.
Publicado: (2020)

Author Correction: Characterization of metal binding of bifunctional kinase/phosphatase AceK and implication in activity modulation
por: Zhang, Xiaoying, et al.
Publicado: (2020)

Author Correction: Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis
por: Singh, Mamta, et al.
Publicado: (2021)

Author Correction: Structural Insight into the MCM double hexamer activation by Dbf4-Cdc7 kinase
por: Cheng, Jiaxuan, et al.
Publicado: (2022)

Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
por: Yeo, Xun Hui, et al.
Publicado: (2023)

Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models
por: Qu, Yiqing, et al.
Publicado: (2014)

Author Correction: Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone
por: Huang, Bin, et al.
Publicado: (2023)

Author Correction: Acylated-acyl carrier protein stabilizes the Pseudomonas aeruginosa WaaP lipopolysaccharide heptose kinase
por: Kreamer, Naomi N. K., et al.
Publicado: (2018)

Author Correction: Revisiting the pH-gated conformational switch on the activities of HisKA-family histidine kinases
por: Mideros-Mora, Cristina, et al.
Publicado: (2020)

Author Correction: The CaMKII/NMDA receptor complex controls hippocampal synaptic transmission by kinase-dependent and independent mechanisms
por: Incontro, Salvatore, et al.
Publicado: (2018)

Author Correction: Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4)
por: Ha, Byung Hak, et al.
Publicado: (2023)

Author Correction: The structural dynamics of macropinosome formation and PI3-kinase-mediated sealing revealed by lattice light sheet microscopy
por: Quinn, Shayne E., et al.
Publicado: (2021)

Author Correction: Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis
por: Novikov, F. N., et al.
Publicado: (2022)

Author Correction: SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis
por: Zhou, Huanjiao Jenny, et al.
Publicado: (2019)

Roles of Polo-like kinase 3 in suppressing tumor angiogenesis
por: Xu, Dazhong, et al.
Publicado: (2012)

A new “angle” on kinase inhibitor design: Prioritizing amphosteric activity above kinase inhibition
por: Meyerowitz, Justin G, et al.
Publicado: (2015)

Author Correction: Identification of a novel cAMP dependent protein kinase A phosphorylation site on the human cardiac calcium channel
por: Szappanos, Henrietta Cserne, et al.
Publicado: (2018)

Author Correction: Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A
por: Olivieri, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p955ssootj23mui3dv5r9pqldd